Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

COUCH Medcomms

- PMLiVE

Enhertu trial results show significant improvement for breast cancer patients

The treatment, jointly developed by AstraZenca and Daiichi Sankyo, was trialled in the pivotal DESTINY-Breast04 study

Biomarin

FDA keeps BioMarin’s gene therapy for phenylketonuria on hold

The decision follows data suggesting BioMarin’s experimental gene therapies may have the potential to progress cancers

EU flag

Global Blood Therapeutics’ treatment for patients with sickle cell disease approved in Europe

The once-daily oral drug is the first medicine approved in Europe to treat the condition in adults and paediatric patients 12 years and older

- PMLiVE

Sandoz launches generic oncology treatment in Europe

Lenalidomide can be used to treat patients with haemato-onocology conditions, following recommendations from recent European Society for Medical Oncology (ESMO) guidelines

Launching Health Tech Innovations in the New Normal

Aahuti Rai (Strategic Advisor, Healthcare Innovation at Four Points Consulting) & Jessica Smith (Co-Founder and CXO at SomX) discuss all things HealthTech, including the current barriers to HealthTech commercialization, holistic...

Impetus Digital

- PMLiVE

Gilead shares results from HIV trial for lenacapavir

The results were presented at the 29th Conference on Retroviruses and Opportunistic Infections – virtual CROI 2022

- PMLiVE

Eli Lilly partners with breast cancer advocacy organisations to raise awareness of risk factors

More than 290,000 women and men are expected to be diagnosed with breast cancer in the US in 2022

- PMLiVE

FREE Live Webinar – Diversity in Clinical Trials – 24th February

Innovative Trials, Pfizer and Parexel invite you to attend the live webinar

Innovative Trials

- PMLiVE

Three predictions for the clinical trial industry in 2022

Kate Shaw, Innovative Trials Founder & CEO, looks ahead to 2022 by listing three predictions for the clinical trial industry in 2022

Innovative Trials

- PMLiVE

MSD and Curve Therapeutics agree on deal potentially worth $1.7bn

The two companies will collaborate on next generation drug discovery

- PMLiVE

AZ’s Saphnelo receives EU approval for systemic lupus erythematosus

There are an estimated 250,000 people living with SLE in Europe and this is the first new drug to gain EU approval in over ten years

- PMLiVE

Onyx Health Tackles Type 2 Diabetes with Diabetes Lifestyle Doctors

Onyx Health has teamed up with Diabetes Lifestyle Doctors to tackle the diabetes care gap in the NHS and help patients suffering from type 2 diabetes across the UK. (Pictured...

Onyx Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links